Animal Vaccines Market

Animal Vaccines Market Size, Share, Growth Analysis, By Type(Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines), By Animal Type(Companion Animal, Livestock Animal, Aquaculture), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2059 | Region: Global | Published Date: July, 2036
Pages: 200 |Tables: 67 |Figures: 75

Animal Vaccines Market Insights

Animal Vaccines Market size was valued at USD 11.68 billion in 2019 and is poised to grow from USD 12.8 billion in 2023 to USD 26.12 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

Increased outbreaks of animal disease and an ever-increasing livestock population are the primary reasons for the wider acceptance of ruminant vaccines, particularly cattle vaccines, around the world. Meat, protein, food, milk, and other commercial products such as wool and leather are all obtained from animals.Rabies vaccines, equine influenza virus vaccines, and foot and mouth disease vaccines are the most commonly used animal vaccines, which prevent the transmission of infectious agents by mimicking naturally immune defense.

Growing concerns about food security, as well as increased animal husbandry, are driving up demand for livestock vaccines. Globally, increased demand for animal products has resulted in increased livestock production. Moreover, various factors such as changing food preferences as a result of changing lifestyles and population growth are driving up demand for livestock products.These factors are assisting the market expansion. The constant introduction of technologically advanced vaccines, as well as the outbreak of livestock diseases, have all contributed to changing market dynamics.

US Animal Vaccines Market  is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 11.68 billion

Largest Segment

Drugs

Fastest Growth

Drugs

Growth Rate

9.4% CAGR

Global Animal Health Market 2021-2027 ($ Mn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Animal Vaccines Market Segmental Analysis

The global animal vaccines market is segmented based on type, animal type and region. Based on type, Animal Vaccines Market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, Animal Vaccines Market is categorized into companion animal, livestock animal, and aquaculture. Based on region, Animal Vaccines Market is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Animal Vaccines Market Analysis by Type

In 2021, the attenuated live vaccines segment dominated the animal vaccines market, with a revenue share of over 36.76%. By activating a wide range of immune responses, attenuated vaccines can provide stronger immunity than other vaccines. Furthermore, it helps to reduce the need for booster vaccines that can be given orally and induces long-lasting and rapid immunity, all of which contribute to the growth of the animal vaccines market. In the veterinary field, live attenuation is the oldest vaccination method. This method is also being tested for the creation of new applications. The development of protein subunit vaccines for swine that are administered intramuscularly is one of these alternatives.

Animal Vaccines Market Analysis by Animal Type

In 2021, the livestock segment dominated the market, accounting for more than 70% of total revenue.  Factors such as rising livestock populations, supportive government initiatives, and disease outbreaks among cattle and sheep can all be blamed for this.  Merck & Co., Inc. has developed vaccines to prevent E. coli, including Aviguard and Nobilis E. coli inac.  According to SQ study, Coli prevalence rates in various cattle categories (feedlot cattle, cattle on irrigated pasture, cattle at slaughter, and cattle grazing rangeland forages) range from 0.2% to 27.8%.

Global Animal Health Market By Product, 2021 (%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Animal Vaccines Market Regional Insights

North America dominated the global market, accounting for more than 27.5% of revenue in 2021.  Throughout the forecast period, the region is expected to maintain its dominant position.  This large proportion can be attributed to the high prevalence of livestock and zoonotic diseases, which result in mass animal deaths.  Furthermore, the large presence of well-established pharmaceutical firms that are consistently striving for broad commercialization of their vaccines and expanding their geographic reach is expected to drive market growth.  Furthermore, rising incidence of canine disorders, which is increasing the adoption of vaccination for the same, and rising pet population in the United States are some of the key factors contributing to the regional market expansion.

The Asia Pacific region is expected to witness fastest growth in the global animal vaccines market. Pet adoption is on the rise, major vaccination players are expanding, product availability is rising, and manufacturing facilities are being invested in across the Asia Pacific, particularly in India, China, and Thailand, boosting market growth.

Global Animal Health Market By Geography, 2021 - 2027, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Animal Vaccines Market Dynamics

Animal Vaccines Market Driver

  • Increasing prevalence of zoonotic diseases has the possibility to get a negative impact on human lives, which is likely to increase demand for animal vaccines. Emerging and exotic animal diseases pose a growing threat to human and animal health, as well as a threat to food security.  The increase in human and animal population, as well as environmental degradation and globalization of trade and travel, increases opportunities for pathogen transmission within and between species.  The resulting diseases present enormous challenges both now and in the future. 
  • Other critical driving factors include technological advancements and the recent release of animal products.  Animal vaccination has undergone significant R&D progressions since it was first introduced to the general public.  Animal vaccination with conventionally attenuated and inactivated pathogens has made critical and significant contributions to the protection of animal and human health.  However, the disadvantages of conventional animal immunization, such as the complex immunogenicity of certain bacterial pathogens, are frequently only partially imitated in inactivated vaccines.  These factors have resulted in the development of recombinant vaccines, which have numerous advantages, including the fact that the vaccinating person is not exposed to the pathogen.

Animal Vaccines Market Restraint

●        In developing countries of Africa, Asia, and Latin America, it is estimated that there are 600-900 million smallholder farmers who own livestock. Animal vaccination adoption among these smallholder farmers is limited due to a variety of factors, including lack of awareness about the benefits, limited accessibility as they cannot afford the cost of the immunization products and dearth of availability due to a weak supply chain. A significant number of livestock animals owned by smallholder farmers die as a result of various diseases, putting them under additional economic strain. Various strategies are being adopted by governments and agencies to improve the adoption of animal immunization among smallholder farmers by increasing accessibility, availability, and affordability.

Request Free Customization of this report to help us to meet your business objectives.

Animal Vaccines Market Competitive Landscape

In terms of the competitive landscape, a few companies have dominated this market due to their strong product portfolios and key strategic decisions. These include 4-5 veterinary vaccine manufacturers with ongoing research and development for new product approvals and a broad geographical presence. The emphasis on inorganic strategies, such as Elanco's acquisition of Bayer's Animal Health division, is expected to further consolidate the major revenue share. With the presence of numerous small and large animal vaccine manufacturers. The rapid adoption of veterinary preventive injections, combined with government-aided bulk purchase of veterinary vaccines, are key factors influencing competition. Furthermore, to maintain market share and diversify product portfolios, major players frequently pursue strategies such as mergers and acquisitions, partnerships, and new product launches.

 

Top Players in the Global Animal Vaccines Market

  • Zoetis
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc.
  • Bayer AG
  • Virbac
  • Ceva
  • HIPRA
  • Hester Biosciences Limited
  • Phibro Animal Health Corporation
  • Biogenesis Bago
  • Vaxxinova
  • IDT Biologika GmbH
  • Bimeda Animal Health
  • BravoVax
  • MSD Animal Health
  • Nexvet
  • Merial
  • Agrovet Market Animal Health
  • Anicon Labor GmbH

Recent Developments

·         In June 2021, Merck Animal Health and Automazioni VX, Inc. have formed a partnership. The primary objective of this partnership was to introduce Innoject Pro, a new subcutaneous chick vaccination technology. The technology will be used in combination with Merck Animal Health's Innovax vaccines, which are designed to protect poultry from infectious diseases.

·         In June 2021, The United Kingdom announced the start of a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, to speed up the development of livestock vaccines and control the spread of viral diseases such as coronavirus.

·         In November 2020, the virtual launch of GUMBOHATCH's new generation Infectious Bursal Disease immune complex immunization product for broiler chickens was announced by HIPRA Indonesia.

Animal Vaccines Key Market Trends

  • Increase in public-private funding for targeted research activities, an increase in the prevalence of animal diseases, and rise in product innovations and development due to global technological advancements will create lucrative opportunities for market participants. The market growth rate will also be boosted in the future by increasing number of strategic alliances, rising internet penetration rate, concerns about animal diseases spreading to humans, technological and biotechnological developments in diagnostics and therapeutics in developing regions, and rising per capita health care spending.

Animal Vaccines Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, increased commercial food animal production has resulted from increased demand for animal protein.  Emerging zoonotic diseases in companion and livestock animals pose a significant risk to public health. The world will inevitably continue to experience emerging disease outbreaks in the coming decades. Therefore, animal vaccines can play a crucial role in controlling emerging diseases.

Report Metric Details
Market size value in 2023 USD 11.68 billion
Market size value in 2031 USD 26.12 billion
Growth Rate 9.4%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines
  • Animal Type
    • Companion Animal, Livestock Animal, Aquaculture
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc.
  • Bayer AG
  • Virbac
  • Ceva
  • HIPRA
  • Hester Biosciences Limited
  • Phibro Animal Health Corporation
  • Biogenesis Bago
  • Vaxxinova
  • IDT Biologika GmbH
  • Bimeda Animal Health
  • BravoVax
  • MSD Animal Health
  • Nexvet
  • Merial
  • Agrovet Market Animal Health
  • Anicon Labor GmbH
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Animal Vaccines Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Animal Vaccines Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Animal Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Animal Vaccines Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Animal Vaccines Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Animal Vaccines Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Animal Vaccines Market size was valued at USD 11.68 billion in 2019 and is poised to grow from USD 12.8 billion in 2023 to USD 26.12 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

In terms of the competitive landscape, a few companies have dominated this market due to their strong product portfolios and key strategic decisions. These include 4-5 veterinary vaccine manufacturers with ongoing research and development for new product approvals and a broad geographical presence. The emphasis on inorganic strategies, such as Elanco's acquisition of Bayer's Animal Health division, is expected to further consolidate the major revenue share. With the presence of numerous small and large animal vaccine manufacturers. The rapid adoption of veterinary preventive injections, combined with government-aided bulk purchase of veterinary vaccines, are key factors influencing competition. Furthermore, to maintain market share and diversify product portfolios, major players frequently pursue strategies such as mergers and acquisitions, partnerships, and new product launches. 'Zoetis', 'Merck & Co., Inc.', 'Boehringer Ingelheim International GmbH', 'Elanco Animal Health Inc.', 'Bayer AG', 'Virbac', 'Ceva', 'HIPRA', 'Hester Biosciences Limited', 'Phibro Animal Health Corporation', 'Biogenesis Bago', 'Vaxxinova', 'IDT Biologika GmbH', 'Bimeda Animal Health', 'BravoVax', 'MSD Animal Health', 'Nexvet', 'Merial', 'Agrovet Market Animal Health', 'Anicon Labor GmbH'

Increasing prevalence of zoonotic diseases has the possibility to get a negative impact on human lives, which is likely to increase demand for animal vaccines. Emerging and exotic animal diseases pose a growing threat to human and animal health, as well as a threat to food security.  The increase in human and animal population, as well as environmental degradation and globalization of trade and travel, increases opportunities for pathogen transmission within and between species.  The resulting diseases present enormous challenges both now and in the future. 

Increase in public-private funding for targeted research activities, an increase in the prevalence of animal diseases, and rise in product innovations and development due to technological advancements will create lucrative opportunities for market participants. The market growth rate will also be boosted in the future by increasing number of strategic alliances, rising internet penetration rate, concerns about animal diseases spreading to humans, technological and biotechnological developments in diagnostics and therapeutics in developing regions, and rising per capita health care spending.

North America dominated the market, accounting for more than 27.5% of revenue in 2021.  Throughout the forecast period, the region is expected to maintain its dominant position.  This large proportion can be attributed to the high prevalence of livestock and zoonotic diseases, which result in mass animal deaths.  Furthermore, the large presence of well-established pharmaceutical firms that are consistently striving for broad commercialization of their vaccines and expanding their geographic reach is expected to drive market growth.  Furthermore, rising incidence of canine disorders, which is increasing the adoption of vaccination for the same, and rising pet population in the United States are some of the key factors contributing to the regional market expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Animal Vaccines Market

Product ID: SQMIG35B2059

$5,300
BUY NOW GET FREE SAMPLE